A carregar...
Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management
Immune checkpoint inhibitor (ICI) associated cardiovascular adverse events (CVAE) have become more frequent with the growing use of cancer immunotherapy. CVAEs include a wide spectrum of diseases such as myocarditis, pericarditis, heart failure, arrhythmias, coronary artery disease, and hypertension...
Na minha lista:
| Publicado no: | Korean Circ J |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Society of Cardiology
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8263294/ https://ncbi.nlm.nih.gov/pubmed/34227272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4070/kcj.2021.0089 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|